To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TOB1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
339 supporting clones for gene TOB1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF962520 nervous_normal .a -10 to 167 24 to 200       177/214
(82 %)
11 diff
(94.9 %id)
DR033861 brain, Right frontal lobe .a 1 to 197 18 to 214       205/214
(95 %)
6 diff
(97.2 %id)
BI544546 brain, hippocampus .a 1 to 417 8 to 428       428/753
(56 %)
14 diff
(98.2 %id)
TI_44000500   .a 1 to 417 157 to 577       427/902
(47 %)
16 diff
(98.3 %id)
BG433761 Kidney .a 1 to 232 5 to 237       237/362
(65 %)
5 diff
(98.7 %id)
BU596779 mixed (pool of 40 RNAs) .a 1 to 721 5 to 737       737/822
(89 %)
47 diff
(94.3 %id)
DA039934 bladder .a 1 to 516 2 to 519   capped   518/518
(100 %)
2 diff
(99.7 %id)
DA182106 amygdala .a 1 to 575 2 to 576   capped   575/575
(100 %)
8 diff
(98.7 %id)
DA545791   .a 1 to 547 2 to 553   capped   552/557
(99 %)
9 diff
(98.4 %id)
DA747276   .a 1 to 532 2 to 540   capped   539/539
(100 %)
5 diff
(99.1 %id)
DA820044   .a 1 to 526 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
DA823416 pericardium .a 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
DA897794 skeletal muscle .a 1 to 436 2 to 437   capped   436/436
(100 %)
0 diff
(100 %id)
DB014647 esophageal, tumor tissue .a 1 to 564 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DB104063 thymus .a 1 to 429 2 to 435   capped   434/441
(98 %)
7 diff
(98.5 %id)
DB198273 trachea .a 1 to 577 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
DB212027 trachea .a 1 to 521 2 to 530   capped   529/529
(100 %)
8 diff
(98.5 %id)
BC098415 Prostate, carcinoma .a 9 to 1478 1 to 1471 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1471/1471
(100 %)
1 diff
(100.0 %id)
BC070493 Uterus, leiomyosarcoma .a 10 to 1478 1 to 1467 exact available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1467/1467
(100 %)
2 diff
(99.9 %id)
BQ919931 carcinoma, cell line, Prostate .a 10 to 880 1 to 882       882/935
(94 %)
8 diff
(99.2 %id)
BQ928853 carcinoma, cell line, Prostate .a 10 to 770 1 to 763       763/987
(77 %)
27 diff
(97.3 %id)
BG898873 cartilage .a 12 to 322 86 to 396       311/330
(94 %)
8 diff
(97.6 %id)
BG900523 cartilage .a 12 to 329 89 to 406       318/334
(95 %)
7 diff
(98.0 %id)
BM562221 leukocyte .a 13 to 893 13 to 906       894/1091
(81 %)
53 diff
(95.2 %id)
EB385368 eye, optic nerve .a 13 to 770 1 to 758       758/758
(100 %)
0 diff
(100 %id)
CV575563 cornea, eye .a 13 to 536 1 to 522       522/522
(100 %)
1 diff
(99.9 %id)
BQ937658 leiomyosarcoma, uterus .a 17 to 880 1 to 885       885/900
(98 %)
43 diff
(95.3 %id)
BQ925701 epidermoid carcinoma, cell line, lung .a 18 to 876 1 to 875       875/948
(92 %)
11 diff
(98.9 %id)
BQ929908 leiomyosarcoma, uterus .a 22 to 884 1 to 883       883/960
(91 %)
31 diff
(96.8 %id)
BU581478 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .a 29 to 655 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
N40270 melanocyte .a 31 to 206 1 to 176       176/176
(100 %)
5 diff
(97.2 %id)
BM475700 embryonal carcinoma, cell line, testis .a 35 to 880 1 to 865       865/967
(89 %)
36 diff
(96.3 %id)
DN993681 brain, whole brain .a 264 to 817 8 to 560       553/560
(98 %)
10 diff
(98.3 %id)
AK313904 caudate nucleus .b 1 to 1466 2 to 1468 exact tiling clone,   1468/1468
(100 %)
1 diff
(100.0 %id)
DA251060 caudate nucleus .b 1 to 579 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
AA308472 colon .b 281 to 671 1 to 390       390/390
(100 %)
5 diff
(98.8 %id)
AV651987 corresponding non cancerous liver tissue .c-u 1 to 409 1 to 409   tiling clone, Submitted on the opposite strand 409/409
(100 %)
0 diff
(100 %id)
CB155928 Liver .c-u 71 to 711 1 to 641   tiling clone,   641/641
(100 %)
0 diff
(100 %id)
BQ322075 colon .c-u 165 to 520 356 to 8       349/356
(98 %)
0 diff
(100 %id)
BQ322077 colon .c-u 165 to 536 378 to 12       367/385
(95 %)
0 diff
(100 %id)
BQ322076 colon .c-u 327 to 548 226 to 1       226/226
(100 %)
12 diff
(94.7 %id)
DA825649 pericardium .c-u 437 to 915 2 to 480   tiling clone, capped   479/479
(100 %)
0 diff
(100 %id)
AW845430 colon .c-u 463 to 727 273 to 12       262/273
(95 %)
0 diff
(100 %id)
AW845449 colon .c-u 463 to 722 262 to 2       261/262
(99 %)
0 diff
(100 %id)
DB195110 trachea .c-u 847 to 1213 2 to 368   tiling clone, capped   367/394
(93 %)
7 diff
(98.3 %id)
DA381643 thalamus .c-u 1146 to 1703 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BF240286 bone marrow, from chronic myelogenous leukemia .c-u 1171 to 1743 572 to 1   available from MGC, Submitted on the opposite strand 572/776
(73 %)
22 diff
(97.2 %id)
BG563214 Liver .c-u 1172 to 1743 572 to 1     Submitted on the opposite strand 572/848
(67 %)
3 diff
(99.7 %id)
CV802406 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c-u 1173 to 1887 1 to 709       709/813
(87 %)
15 diff
(98.2 %id)
TI_151759527   .c-u 1177 to 1939 813 to 48       766/1066
(71 %)
0 diff
(100 %id)
AW339826 pooled .c-u 1178 to 1477 307 to 3       305/311
(98 %)
0 diff
(100 %id)
BC015064 Bone marrow, chronic myelogenous leukemia .c-u 1178 to 1746 574 to 1   available from MGC, AAA Submitted on the opposite strand 574/575
(99 %)
5 diff
(99.2 %id)
BQ220150 melanotic melanoma, skin .c-u 1178 to 1736 44 to 612       569/921
(61 %)
30 diff
(96.8 %id)
BM719133 eye, fetal eye .c-u 1178 to 1852 31 to 707       677/707
(95 %)
6 diff
(99.2 %id)
CB243477 Human Lung Epithelial cells, lung .c-u 1182 to 1977 1 to 795   tiling clone, Submitted on the opposite strand 795/795
(100 %)
2 diff
(99.8 %id)
AI689016 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c-u 1183 to 1561 1 to 377     Submitted on the opposite strand 377/377
(100 %)
3 diff
(99.3 %id)
AA765285 germinal center B cell .c-u 1187 to 1620 1 to 426     Submitted on the opposite strand 426/426
(100 %)
12 diff
(97.2 %id)
AI057639 parathyroid gland, parathyroid tumor .c-u 1192 to 1862 1 to 671     Submitted on the opposite strand 671/671
(100 %)
0 diff
(100 %id)
BE047246 ovary, serous papillary tumor .c-u 1192 to 1771 1 to 580     Submitted on the opposite strand 580/581
(99 %)
10 diff
(98.3 %id)
AA724360 parathyroid gland, parathyroid tumor .c-u 1194 to 1804 1 to 609     Submitted on the opposite strand 609/609
(100 %)
3 diff
(99.6 %id)
D38305 breast cancer .c-u 1196 to 2398 2 to 1206 exact     1205/1206
(99 %)
6 diff
(99.6 %id)
AA971873 carcinoid, lung .c-u 1198 to 1635 1 to 434     Submitted on the opposite strand 434/434
(100 %)
4 diff
(99.1 %id)
BE465125 carcinoid, lung .c-u 1198 to 1594 1 to 397     Submitted on the opposite strand 397/397
(100 %)
1 diff
(99.8 %id)
BQ307348 breast .c-u 1199 to 1763 14 to 578       565/578
(97 %)
6 diff
(99.0 %id)
W96163 eye, retina .c-u 1199 to 1595 1 to 401     Submitted on the opposite strand 401/401
(100 %)
10 diff
(97.6 %id)
H69174 liver and spleen .c-u 1200 to 1484 1 to 284     Submitted on the opposite strand 284/284
(100 %)
3 diff
(99.0 %id)
N47085 multiple sclerosis lesions .c-u 1200 to 1642 1 to 443     Submitted on the opposite strand 443/443
(100 %)
3 diff
(99.4 %id)
AA490213 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c-u 1200 to 1586 1 to 387     Submitted on the opposite strand 387/387
(100 %)
2 diff
(99.5 %id)
AI796798 carcinoid, lung .c-u 1200 to 1595 1 to 395     Submitted on the opposite strand 395/395
(100 %)
8 diff
(98.0 %id)
NM_005749.2   .c-u 1204 to 3033 1 to 1830 exact RefSeq,   1830/1830
(100 %)
1 diff
(100.0 %id)
BU184939 epithelioid carcinoma, Pancreas .c-u 1208 to 2096 1 to 897       897/908
(98 %)
36 diff
(96.1 %id)
TI_57216753   .c-u 1216 to 2109 19 to 902       884/905
(97 %)
6 diff
(99.4 %id)
TI_153954981   .c-u 1219 to 1714 80 to 575     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 496/516
(96 %)
33 diff
(93.7 %id)
AA297271 endometrium .c-u 1220 to 1557 1 to 336       336/336
(100 %)
3 diff
(99.2 %id)
AA601927   .c-u 1227 to 1613 1 to 387       387/387
(100 %)
11 diff
(97.2 %id)
AY524047   .c-u 1229 to 2315 1 to 1087 I94V     1087/1087
(100 %)
2 diff
(99.9 %id)
BG289560 bladder, transitional cell papilloma, cell line .c-u 1230 to 1923 1 to 698       698/699
(99 %)
16 diff
(97.8 %id)
TI_1948122131   .c-u 1231 to 1731 121 to 607   fully sequenced,   487/607
(80 %)
5 diff
(99.2 %id)
BC031406 Brain, adult, 6 pooled whole brains .c-u 1232 to 3028 1 to 1797 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1797/1797
(100 %)
1 diff
(100.0 %id)
BJ992081 hepatoblastoma .c-u 1232 to 1705 1 to 474     Submitted on the opposite strand 474/474
(100 %)
0 diff
(100 %id)
BI756802 brain .c-u 1232 to 2109 1 to 868       868/871
(99 %)
26 diff
(97.1 %id)
BI858075 breast, mammary adenocarcinoma, cell line .c-u 1232 to 1979 29 to 775       747/776
(96 %)
6 diff
(99.3 %id)
TI_57187834   .c-u 1232 to 1979 85 to 831       747/776
(96 %)
6 diff
(99.3 %id)
TI_1948122304   .c-u 1232 to 2258 124 to 1161   fully sequenced,   1038/1161
(89 %)
6 diff
(99.5 %id)
BT019380   .c-u 1239 to 2275 1 to 1037   tiling clone,   1037/1038
(99 %)
2 diff
(99.9 %id)
BT019381   .c-u 1239 to 2275 1 to 1037       1037/1038
(99 %)
2 diff
(99.9 %id)
CR536487   .c-u 1239 to 2276 1 to 1038 exact     1038/1038
(100 %)
1 diff
(100.0 %id)
CR541686   .c-u 1239 to 2273 1 to 1035       1035/1035
(100 %)
1 diff
(100.0 %id)
CV029614 mixed .c-u 1239 to 1857 1 to 618       618/618
(100 %)
2 diff
(99.7 %id)
AI693926 pooled .c-u 1241 to 1860 1 to 620     Submitted on the opposite strand 620/622
(99 %)
63 diff
(89.9 %id)
BP274533 Kidney .c-u 1246 to 1825 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP264998 muscle .c-u 1250 to 1942 1 to 692       692/695
(99 %)
11 diff
(98.5 %id)
BI838496 pooled pancreas and spleen .c-u 1263 to 2123 1 to 865       865/866
(99 %)
14 diff
(98.4 %id)
TI_57163135   .c-u 1263 to 2123 45 to 909       865/910
(95 %)
14 diff
(98.5 %id)
AI366102 brain, meningioma .c-u 1269 to 1796 1 to 528     Submitted on the opposite strand 528/528
(100 %)
0 diff
(100 %id)
DA264074 caudate nucleus .c-u 1271 to 1828 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA608582   .c-u 1276 to 1776 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA015618 adrenal gland .c-u 1280 to 1842 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
AI366219 brain, meningioma .c-u 1286 to 1710 1 to 425     Submitted on the opposite strand 425/425
(100 %)
0 diff
(100 %id)
TI_1948122132   .c-u 1701 to 2282 702 to 120   fully sequenced,   583/702
(83 %)
6 diff
(99.2 %id)
TI_1948122305   .c-u 1771 to 2278 633 to 116   fully sequenced,   518/633
(81 %)
8 diff
(98.8 %id)
TI_151738210   .c-u 2526 to 3025 642 to 139   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 504/944
(53 %)
0 diff
(100 %id)
BJ992080 hepatoblastoma .c-u 2589 to 2996 408 to 1     Submitted on the opposite strand 408/408
(100 %)
1 diff
(99.8 %id)
BM759148 lymph node, stomach .d 1 to 360 5 to 364       364/364
(100 %)
3 diff
(99.2 %id)
DA907335   .d 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
DB208273 trachea .d 1 to 502 2 to 503   capped   502/502
(100 %)
2 diff
(99.7 %id)
AA675891   .d 86 to 888 1 to 803       803/803
(100 %)
3 diff
(99.7 %id)
H29950 eye, retina .d 288 to 611 1 to 324       324/324
(100 %)
1 diff
(99.7 %id)
BM360875 rectum .d 289 to 848 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
AA297035 brain, cerebellum .d 302 to 623 1 to 324       324/324
(100 %)
4 diff
(98.8 %id)
BF170818 blood .d 305 to 547 1 to 240       240/240
(100 %)
18 diff
(92.5 %id)
BG900560 cartilage .d 308 to 604 77 to 372       296/304
(97 %)
6 diff
(98.1 %id)
AW361458 colon .d 310 to 830 521 to 1       521/521
(100 %)
9 diff
(98.3 %id)
R85904 eye, retina .d 311 to 455 1 to 145     Submitted on the opposite strand 145/145
(100 %)
1 diff
(99.4 %id)
CA453929   .d 318 to 1185 1 to 874       874/878
(99 %)
8 diff
(99.1 %id)
BM688735 eye, eye anterior segment .d 332 to 825 1 to 494     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 494/494
(100 %)
5 diff
(99.0 %id)
BP246928 Kidney .d 334 to 925 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
AA019926 eye, retina .d 335 to 909 1 to 583       583/583
(100 %)
12 diff
(98.0 %id)
BF239028 bone marrow, from chronic myelogenous leukemia .d 338 to 978 623 to 1     Submitted on the opposite strand 623/852
(73 %)
15 diff
(98.3 %id)
TI_1948122485   .d 363 to 1281 1036 to 123 V203F *207Y K208P K209T     914/1175
(77 %)
0 diff
(100 %id)
AA017154 eye, retina .d 368 to 443 1 to 76     Submitted on the opposite strand 76/76
(100 %)
0 diff
(100 %id)
DN919669   .d 386 to 615 16 to 246       231/246
(93 %)
11 diff
(95.6 %id)
TI_1948122654   .d 393 to 1281 1016 to 124   tiling clone,   893/1225
(72 %)
0 diff
(100 %id)
BF971199 adrenal cortex carcinoma, cell line, adrenal gland .d 401 to 1118 1 to 716       716/717
(99 %)
6 diff
(99.2 %id)
EY198503 intestinal (Lauren) gastric adenocarcinoma, stomach .d 415 to 848 434 to 1     Submitted on the opposite strand 434/434
(100 %)
0 diff
(100 %id)
EY198507 intestinal (Lauren) gastric adenocarcinoma, stomach .d 422 to 848 427 to 1     Submitted on the opposite strand 427/427
(100 %)
4 diff
(99.1 %id)
AV709945 adrenal gland .d 428 to 1065 1 to 639       639/712
(89 %)
23 diff
(96.8 %id)
CU443815 epidermis .d 432 to 857 448 to 23     Submitted on the opposite strand 426/456
(93 %)
0 diff
(100 %id)
CU443996 epidermis .d 432 to 857 448 to 23     Submitted on the opposite strand 426/479
(88 %)
0 diff
(100 %id)
BF176203 blood .d 442 to 640 1 to 203       203/203
(100 %)
9 diff
(95.6 %id)
FN109745 breast carcinoma .d 445 to 536 91 to 1     Submitted on the opposite strand 91/95
(95 %)
2 diff
(97.9 %id)
DN919668   .d 447 to 712 268 to 3       266/268
(99 %)
0 diff
(100 %id)
AW578667 colon .d 454 to 681 1 to 226       226/226
(100 %)
7 diff
(97.0 %id)
AW368046 head_neck .d 460 to 770 1 to 311       311/328
(94 %)
4 diff
(98.8 %id)
CN410581 embryonic stem cells, cell lines H1, H7, andH9 .d 485 to 1163 1 to 680       680/680
(100 %)
2 diff
(99.8 %id)
AA296952 colon .d 488 to 802 1 to 314       314/314
(100 %)
5 diff
(98.5 %id)
BF037699 adenocarcinoma, ovary .d 489 to 993 1 to 501       501/512
(97 %)
6 diff
(98.9 %id)
C19055 placenta .d 502 to 829 1 to 327       327/327
(100 %)
14 diff
(95.8 %id)
AW600933 breast_normal .d 518 to 963 9 to 453       445/453
(98 %)
8 diff
(98.3 %id)
CK816193 breast, cancer cells growing in a xenograft mousemodel .d 521 to 1114 621 to 30     Submitted on the opposite strand 592/801
(73 %)
0 diff
(100 %id)
AW369569 breast_normal .d 527 to 982 39 to 495       457/526
(86 %)
17 diff
(96.8 %id)
AA011368 liver and spleen .d 531 to 904 1 to 379   fully sequenced,   379/379
(100 %)
7 diff
(98.2 %id)
H75565 liver and spleen .d 532 to 883 1 to 356   fully sequenced,   356/356
(100 %)
5 diff
(98.6 %id)
BG261319 bladder, transitional cell papilloma, cell line .d 533 to 1248 1 to 725       725/1039
(69 %)
29 diff
(97.3 %id)
BF869517 lung_tumor .d 542 to 976 454 to 20     Submitted on the opposite strand 435/454
(95 %)
0 diff
(100 %id)
BG899228 cartilage .d 561 to 889 77 to 405       329/346
(95 %)
4 diff
(98.9 %id)
BM789265 stomach .d 568 to 1245 1 to 677       677/678
(99 %)
2 diff
(99.8 %id)
BM830192 stomach .d 574 to 1157 1 to 584       584/584
(100 %)
0 diff
(100 %id)
H69173 liver and spleen .d 588 to 999 419 to 2     Submitted on the opposite strand 418/421
(99 %)
0 diff
(100 %id)
CD721994 eye, lacrimal gland .d 592 to 1224 1 to 633       633/633
(100 %)
0 diff
(100 %id)
CU449350 epidermis .d 600 to 916 328 to 13     Submitted on the opposite strand 316/341
(92 %)
0 diff
(100 %id)
CU448988 epidermis .d 604 to 916 326 to 13     Submitted on the opposite strand 314/329
(95 %)
0 diff
(100 %id)
CB163771 Liver .d 619 to 1181 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BM829613 stomach .d 626 to 969 1 to 344       344/344
(100 %)
17 diff
(95.1 %id)
AV686332 hepatocellular carcinoma .d 651 to 1392 1 to 734 P111X P113X S189T N192T M193C ...     734/736
(99 %)
25 diff
(96.7 %id)
AV696202 hepatocellular carcinoma .d 651 to 1380 1 to 727 P17T P113X F135C F137X N191X     727/738
(98 %)
12 diff
(98.4 %id)
BQ325273 colon_ins .d 652 to 858 234 to 21       214/240
(89 %)
0 diff
(100 %id)
AI694204 carcinoid, lung .d 654 to 1278 625 to 1 P30X K52X A205E     625/625
(100 %)
4 diff
(99.4 %id)
BE777486 bone marrow, from chronic myelogenous leukemia .d 670 to 1316 1 to 641       641/794
(80 %)
23 diff
(97.2 %id)
BE785128 large cell carcinoma, lung .d 681 to 1354 1 to 667       667/914
(72 %)
14 diff
(98.5 %id)
FN115347 breast carcinoma .d 696 to 798 1 to 107       107/108
(99 %)
5 diff
(95.4 %id)
BE868852 adenocarcinoma, colon .d 707 to 1283 1 to 578       578/730
(79 %)
8 diff
(99.0 %id)
FN170925 breast carcinoma .d 708 to 787 1 to 79       79/79
(100 %)
5 diff
(93.7 %id)
CA311131 Human Lung Epithelial cells, lung .d 712 to 1288 582 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 577/582
(99 %)
0 diff
(100 %id)
AI940173 colon .d 718 to 965 248 to 1       248/253
(98 %)
1 diff
(99.7 %id)
AI940169 colon .d 727 to 963 1 to 237       237/243
(97 %)
2 diff
(99.2 %id)
AI940180 colon .d 727 to 959 249 to 17       233/249
(93 %)
0 diff
(100 %id)
AI940223 colon .d 727 to 955 1 to 229       229/229
(100 %)
2 diff
(99.2 %id)
AI940148 colon .d 732 to 965 1 to 232       232/232
(100 %)
10 diff
(95.7 %id)
AI940159 colon .d 733 to 959 1 to 227       227/238
(95 %)
11 diff
(95.4 %id)
AI940164 colon .d 733 to 875 1 to 143       143/151
(94 %)
8 diff
(94.8 %id)
AI940147 colon .d 735 to 959 1 to 224       224/237
(94 %)
7 diff
(97.1 %id)
AI940143 colon .d 737 to 959 12 to 233       222/233
(95 %)
6 diff
(97.5 %id)
AA452505   .d 777 to 1212 1 to 436       436/436
(100 %)
0 diff
(100 %id)
BX117948   .d 778 to 1440 1 to 663       663/670
(98 %)
3 diff
(99.6 %id)
CR742293   .d 778 to 1464 1 to 687       687/687
(100 %)
2 diff
(99.8 %id)
BF239365 bone marrow, from chronic myelogenous leukemia .d 779 to 1371 1 to 583       583/818
(71 %)
13 diff
(98.5 %id)
BU634494 cell lines, Chondrosarcoma .d 791 to 1288 503 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 498/503
(99 %)
0 diff
(100 %id)
BU603597 mixed (pool of 40 RNAs) .d 792 to 1124 1 to 333       333/836
(39 %)
2 diff
(99.8 %id)
BG709338 brain, hypothalamus .d 793 to 1399 1 to 617       617/863
(71 %)
11 diff
(98.8 %id)
BI599234 brain, hypothalamus .d 793 to 1575 1 to 789       789/987
(79 %)
27 diff
(97.3 %id)
TI_45215017   .d 797 to 1575 93 to 877       785/1075
(73 %)
24 diff
(97.8 %id)
DB496117 hypothalamus .d 801 to 1286 1 to 486       486/486
(100 %)
2 diff
(99.6 %id)
AA402073 ovarian tumor, ovary .d 801 to 1061 1 to 261       261/261
(100 %)
1 diff
(99.7 %id)
AA296983 adrenal gland .d 808 to 1121 1 to 314       314/314
(100 %)
1 diff
(99.7 %id)
BP323456 Pancreas .d 809 to 1393 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
BM696880 eye, lens .d 809 to 1239 1 to 431     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 431/431
(100 %)
1 diff
(99.8 %id)
BP342302 stomach mucosa .d 811 to 1393 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
BI964763 Islets of Langerhans, Pancreas .d 818 to 1316 1 to 499       499/499
(100 %)
3 diff
(99.4 %id)
CK903415 Islets of Langerhans, Pancreas .d 818 to 1205 1 to 388       388/388
(100 %)
2 diff
(99.5 %id)
CU450230 epidermis .d 827 to 1170 353 to 10     Submitted on the opposite strand 344/355
(96 %)
0 diff
(100 %id)
FN067937 breast carcinoma .d 852 to 920 1 to 68       68/68
(100 %)
1 diff
(98.6 %id)
H73435 liver and spleen .d 853 to 1280 436 to 1   fully sequenced,   436/436
(100 %)
12 diff
(97.3 %id)
AA298646 small intestine .d 859 to 1105 1 to 247       247/247
(100 %)
0 diff
(100 %id)
AW971323   .d 859 to 1288 106 to 535   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 430/625
(68 %)
8 diff
(98.8 %id)
AA425611   .d 862 to 1402 1 to 541     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 541/541
(100 %)
0 diff
(100 %id)
AA429424   .d 862 to 1302 1 to 441     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 441/441
(100 %)
0 diff
(100 %id)
BG290462 bladder, transitional cell papilloma, cell line .d 864 to 1508 1 to 651       651/1009
(64 %)
20 diff
(98.1 %id)
CN410582 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 867 to 1613 1 to 747       747/747
(100 %)
2 diff
(99.8 %id)
BF680297 Prostate .d 868 to 1400 1 to 537       537/815
(65 %)
18 diff
(97.8 %id)
BM662548 eye, eye anterior segment .d 871 to 1288 423 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 418/423
(98 %)
0 diff
(100 %id)
AA011380 liver and spleen .d 874 to 1275 402 to 1   fully sequenced,   402/402
(100 %)
0 diff
(100 %id)
AA580174 breast .d 915 to 1264 350 to 1       350/350
(100 %)
5 diff
(98.6 %id)
N50297 multiple sclerosis lesions .d 921 to 1195 277 to 2     Submitted on the opposite strand 276/280
(98 %)
0 diff
(100 %id)
BF701231 brain, primitive neuroectoderm .d 930 to 1546 1 to 617       617/835
(73 %)
19 diff
(97.8 %id)
BG178975 adenocarcinoma, cell line, Prostate .d 933 to 1535 1 to 602       602/1028
(58 %)
5 diff
(99.6 %id)
CX786201 human embryonic stem cells .d 938 to 1736 23 to 821       799/821
(97 %)
6 diff
(99.3 %id)
AA129969 uterus .d 960 to 1401 1 to 454       454/459
(98 %)
17 diff
(96.3 %id)
AA258452 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 974 to 1432 1 to 460       460/460
(100 %)
3 diff
(99.4 %id)
H29857 eye, retina .d 979 to 1275 301 to 1       301/303
(99 %)
12 diff
(96.1 %id)
BF574462 muscle (skeletal) .d 989 to 1510 1 to 528       528/528
(100 %)
17 diff
(96.8 %id)
BG928435 cartilage .d 1005 to 1303 69 to 366   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 298/304
(98 %)
6 diff
(98.1 %id)
EC465844 Prostate .d 1009 to 1087 1 to 77       77/92
(83 %)
3 diff
(96.8 %id)
AA503079 colon .d 1012 to 1322 215 to 525     Submitted on the opposite strand 311/525
(59 %)
6 diff
(98.9 %id)
BF790656 muscle (skeletal) .d 1018 to 1601 1 to 597       597/650
(91 %)
46 diff
(93.0 %id)
EL947287 eyeball .d 1019 to 1532 1 to 514       514/514
(100 %)
13 diff
(97.5 %id)
AA675892   .d 1021 to 2029 1005 to 1       1005/1005
(100 %)
11 diff
(99.0 %id)
AW274128 pooled .d 1029 to 1272 244 to 1       244/301
(81 %)
9 diff
(97.1 %id)
AV705455 adrenal gland .d 1035 to 1408 1 to 375       375/375
(100 %)
3 diff
(99.2 %id)
BF028517 bladder, carcinoma, cell line .d 1039 to 1584 1 to 544       544/857
(63 %)
33 diff
(96.2 %id)
BM930898 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1044 to 1561 1 to 518   fully sequenced, Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 518/518
(100 %)
0 diff
(100 %id)
FN106564 breast carcinoma .d 1049 to 1161 112 to 1     Submitted on the opposite strand 112/112
(100 %)
1 diff
(99.2 %id)
BG565422 Liver .d 1075 to 1863 1 to 788       788/797
(98 %)
44 diff
(94.5 %id)
W52346 senescent fibroblast .d 1100 to 1566 1 to 470       470/478
(98 %)
4 diff
(99.2 %id)
BG484954 lung .d 1105 to 1720 1 to 624       624/822
(75 %)
47 diff
(94.3 %id)
BG482748 lung .d 1118 to 1787 1 to 681       681/681
(100 %)
49 diff
(92.9 %id)
G43248   .d 1131 to 1277 150 to 4     Submitted on the opposite strand 147/150
(98 %)
0 diff
(100 %id)
BG533309 Liver .d 1148 to 1716 1 to 574       574/1067
(53 %)
39 diff
(96.4 %id)
AV707978 adrenal gland .d 1150 to 1542 1 to 393       393/397
(98 %)
2 diff
(99.5 %id)
CB069380 Pancreas, Purified pancreatic islet .d 1152 to 1608 6 to 462   tiling clone, fully sequenced,   457/462
(98 %)
5 diff
(99.0 %id)
CA942284 Pancreas, Purified pancreatic islet .d 1152 to 1515 6 to 369   fully sequenced,   364/369
(98 %)
5 diff
(98.7 %id)
AV727073 hypothalamus .d 1154 to 1881 1 to 727       727/729
(99 %)
13 diff
(98.3 %id)
AW887151 ovary .d 1165 to 1697 536 to 5       532/536
(99 %)
0 diff
(100 %id)
FN127704 breast carcinoma .d 1168 to 1263 96 to 1     Submitted on the opposite strand 96/97
(98 %)
4 diff
(95.9 %id)
BF970671 adrenal cortex carcinoma, cell line, adrenal gland .d 1172 to 1993 1 to 819       819/885
(92 %)
73 diff
(91.8 %id)
AW887165 ovary .d 1173 to 1697 533 to 12       522/534
(97 %)
0 diff
(100 %id)
FN061717 breast carcinoma .d 1190 to 1261 1 to 72       72/78
(92 %)
3 diff
(96.2 %id)
CB957364 Pooled-Glandular .d 1201 to 1940 1 to 749       749/750
(99 %)
17 diff
(97.8 %id)
AV756031 bone marrow .d 1206 to 1641 71 to 497       427/500
(85 %)
13 diff
(97.4 %id)
BF213627 bone marrow, from acute myelogenous leukemia .d 1210 to 1725 1 to 512       512/786
(65 %)
22 diff
(97.3 %id)
BU948910 Pancreas, Purified pancreatic islet .d 1236 to 1673 1 to 441   fully sequenced,   441/441
(100 %)
6 diff
(98.7 %id)
AV705659 adrenal gland .d 1268 to 1957 1 to 690       690/700
(98 %)
19 diff
(97.3 %id)
TI_149295832   .d 1278 to 2029 833 to 93   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 741/905
(81 %)
13 diff
(98.6 %id)
CB240791 Human Lung Epithelial cells, lung .d 1295 to 2029 754 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 736/748
(98 %)
2 diff
(99.8 %id)
CF887419 Human Lung Epithelial cells, lung .d 1296 to 2028 1 to 734   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 734/734
(100 %)
3 diff
(99.6 %id)
AL703169 human skeletal muscle .d 1312 to 2032 729 to 11     Submitted on the opposite strand 719/729
(98 %)
0 diff
(100 %id)
DW409841 Liver .d 1318 to 1638 17 to 337       321/337
(95 %)
6 diff
(98.3 %id)
BP424534 small intestine .d 1329 to 1786 1 to 457     Submitted on the opposite strand 457/457
(100 %)
3 diff
(99.4 %id)
BF733665 amnion_normal .d 1347 to 1517 172 to 2     Submitted on the opposite strand 171/172
(99 %)
0 diff
(100 %id)
BU617890 Bone, Subchondral Bone .d 1354 to 2029 695 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 677/677
(100 %)
1 diff
(99.9 %id)
T25056   .d 1359 to 1539 1 to 181       181/181
(100 %)
0 diff
(100 %id)
AA707934 pineal gland .d 1364 to 1573 210 to 1       210/210
(100 %)
0 diff
(100 %id)
BQ020633 Fibrosarcoma .d 1370 to 2029 678 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BG898641 cartilage .d 1371 to 2020 698 to 49       650/698
(93 %)
0 diff
(100 %id)
BM746150 stomach .d 1382 to 1896 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
BQ007908 Chondrosarcoma, Left Pelvis .d 1383 to 2029 659 to 13   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 647/647
(100 %)
14 diff
(97.9 %id)
AA348734 brain, hippocampus .d 1384 to 1715 1 to 332       332/332
(100 %)
1 diff
(99.7 %id)
BU683928 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 1405 to 2029 642 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 624/627
(99 %)
2 diff
(99.7 %id)
BU581175 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .d 1411 to 2032 622 to 1       622/622
(100 %)
0 diff
(100 %id)
D63018   .d 1417 to 1638 1 to 222       222/222
(100 %)
2 diff
(99.1 %id)
BQ637275 eye, retina .d 1422 to 2004 1 to 583       583/583
(100 %)
0 diff
(100 %id)
R66546 placenta .d 1438 to 1754 1 to 321   fully sequenced, AAA   321/321
(100 %)
3 diff
(99.1 %id)
BM153377 leukopheresis .d 1442 to 2023 604 to 23   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 582/582
(100 %)
3 diff
(99.5 %id)
BG926164 cartilage .d 1448 to 1993 93 to 641       549/573
(95 %)
6 diff
(99.0 %id)
BX487716   .d 1448 to 2034 638 to 52     Submitted on the opposite strand 587/638
(92 %)
0 diff
(100 %id)
D62372   .d 1453 to 1794 1 to 342       342/342
(100 %)
3 diff
(99.2 %id)
BF059277 pooled germ cell tumors .d 1457 to 2029 573 to 1       573/573
(100 %)
0 diff
(100 %id)
AI634106 pooled germ cell tumors .d 1458 to 1952 495 to 1       495/495
(100 %)
0 diff
(100 %id)
AA297460 endometrium .d 1459 to 1842 1 to 382       382/383
(99 %)
6 diff
(98.5 %id)
BM991424 lung, Metastatic Chondrosarcoma .d 1477 to 2029 571 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 553/553
(100 %)
0 diff
(100 %id)
CA844075 Pancreas, Purified pancreatic islet .d 1485 to 2031 547 to 1   fully sequenced,   547/547
(100 %)
0 diff
(100 %id)
AV758241 bone marrow .d 1490 to 1884 60 to 454       395/472
(83 %)
4 diff
(99.2 %id)
AW268878 pooled .d 1502 to 2033 532 to 1       532/532
(100 %)
0 diff
(100 %id)
BU858947 mixed (pool of 40 RNAs) .d 1509 to 2029 1 to 521   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 521/521
(100 %)
2 diff
(99.7 %id)
BU953336 mixed (pool of 40 RNAs) .d 1509 to 2030 1 to 522       522/814
(64 %)
2 diff
(99.8 %id)
AW009723 colon .d 1511 to 2034 526 to 3   tiling clone,   524/526
(99 %)
0 diff
(100 %id)
AA425394   .d 1523 to 2023 516 to 16   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 501/501
(100 %)
0 diff
(100 %id)
D58356   .d 1529 to 1809 1 to 279       279/279
(100 %)
7 diff
(97.5 %id)
BU735467 eye, lens .d 1530 to 2029 512 to 13   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 500/500
(100 %)
0 diff
(100 %id)
BM684416 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1531 to 2029 514 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 496/496
(100 %)
1 diff
(99.8 %id)
BP383984 pancreatic islet .d 1536 to 2034 1 to 499     Submitted on the opposite strand 499/500
(99 %)
1 diff
(99.8 %id)
AI754632 bone marrow stroma .d 1537 to 2029 525 to 34   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 492/492
(100 %)
1 diff
(99.8 %id)
BG283691 adenocarcinoma, cell line, Prostate .d 1545 to 2029 29 to 513   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 485/513
(94 %)
6 diff
(98.9 %id)
AW080100 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1549 to 1722 174 to 1       174/174
(100 %)
0 diff
(100 %id)
AI635978 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1554 to 1722 169 to 1       169/169
(100 %)
0 diff
(100 %id)
AW070568 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .d 1554 to 1722 169 to 1       169/169
(100 %)
0 diff
(100 %id)
AW189175 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1554 to 1722 169 to 1       169/169
(100 %)
0 diff
(100 %id)
DR423447 eye, Pterygium .d 1558 to 2029 1 to 472   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 472/472
(100 %)
1 diff
(99.8 %id)
AI597919 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1559 to 1722 164 to 1       164/164
(100 %)
0 diff
(100 %id)
AW241651 Kidney .d 1562 to 2029 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AI863508 Kidney .d 1564 to 2029 467 to 1       467/467
(100 %)
1 diff
(99.8 %id)
AW950655   .d 1567 to 2028 464 to 1     Submitted on the opposite strand 464/498
(93 %)
28 diff
(94.4 %id)
D62079   .d 1567 to 1834 1 to 267       267/267
(100 %)
5 diff
(98.2 %id)
AA428367   .d 1567 to 2023 472 to 16   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
AI270026 colon, moderately-differentiated adenocarcinoma .d 1569 to 2031 464 to 1       464/464
(100 %)
2 diff
(99.6 %id)
DB567126 hypothalamus .d 1573 to 2029 1 to 456   AAA Submitted on the opposite strand 456/456
(100 %)
1 diff
(99.8 %id)
AI376247   .d 1575 to 2013 462 to 23       440/462
(95 %)
0 diff
(100 %id)
CB069145 Pancreas, Purified pancreatic islet .d 1578 to 2031 454 to 1   fully sequenced,   454/454
(100 %)
0 diff
(100 %id)
AV720289 corresponding non cancerous liver tissue .d 1582 to 2023 442 to 1     Submitted on the opposite strand 442/442
(100 %)
0 diff
(100 %id)
AA972087 pooled .d 1588 to 2029 442 to 1       442/443
(99 %)
0 diff
(100 %id)
AA828524 germinal center B cell .d 1592 to 2029 449 to 12   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 438/439
(99 %)
2 diff
(99.6 %id)
AI471670 colon, moderately-differentiated adenocarcinoma .d 1598 to 1722 125 to 1       125/125
(100 %)
0 diff
(100 %id)
BM360856 rectum .d 1605 to 1776 171 to 1       171/171
(100 %)
1 diff
(99.5 %id)
BP390800 pancreatic islet .d 1606 to 2029 1 to 425     Submitted on the opposite strand 425/425
(100 %)
1 diff
(99.8 %id)
AI634619 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1609 to 1722 114 to 1       114/114
(100 %)
0 diff
(100 %id)
AI376248   .d 1610 to 2034 425 to 1       425/425
(100 %)
0 diff
(100 %id)
AI597828 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1610 to 1722 113 to 1       113/113
(100 %)
0 diff
(100 %id)
AA454090   .d 1615 to 2032 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AA719600 pineal gland .d 1629 to 2029 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
AA129970 uterus .d 1629 to 2031 410 to 1       410/411
(99 %)
11 diff
(97.4 %id)
BU948659 Pancreas, Purified pancreatic islet .d 1643 to 2038 396 to 1   fully sequenced,   396/396
(100 %)
8 diff
(98.0 %id)
BQ022619 placenta .d 1649 to 2029 400 to 20   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 381/381
(100 %)
5 diff
(98.7 %id)
CA844138 Pancreas, Purified pancreatic islet .d 1652 to 2031 380 to 1       380/380
(100 %)
3 diff
(99.3 %id)
AI266158 lung .d 1661 to 2034 377 to 4       374/377
(99 %)
0 diff
(100 %id)
FN062112 breast carcinoma .d 1671 to 1776 105 to 1     Submitted on the opposite strand 105/105
(100 %)
1 diff
(99.1 %id)
AA258382 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1673 to 2024 352 to 1       352/352
(100 %)
0 diff
(100 %id)
W96255 eye, retina .d 1676 to 2021 347 to 1     Submitted on the opposite strand 347/347
(100 %)
1 diff
(99.8 %id)
AW340768 2 pooled tumors (clear cell type), Kidney .d 1682 to 2030 350 to 2       349/350
(99 %)
0 diff
(100 %id)
BU953632 mixed (pool of 40 RNAs) .d 1683 to 2034 1 to 358       358/362
(98 %)
13 diff
(96.5 %id)
D20342   .d 1685 to 1884 1 to 202     Submitted on the opposite strand 202/204
(99 %)
7 diff
(96.6 %id)
BU565385 mixed (pool of 40 RNAs) .d 1694 to 2034 1 to 341       341/802
(42 %)
2 diff
(99.8 %id)
AI648668 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1695 to 2034 341 to 2       340/341
(99 %)
0 diff
(100 %id)
W52405 senescent fibroblast .d 1700 to 2034 336 to 1       336/358
(93 %)
1 diff
(99.8 %id)
AA876530 epithelium (cell line), Prostate .d 1711 to 2034 338 to 15       324/338
(95 %)
0 diff
(100 %id)
AA953264 2 pooled tumors (clear cell type), Kidney .d 1712 to 2029 318 to 1       318/318
(100 %)
0 diff
(100 %id)
D61818   .d 1718 to 1987 1 to 269       269/269
(100 %)
3 diff
(98.9 %id)
D58009   .d 1718 to 2033 1 to 316   fully sequenced,   316/316
(100 %)
3 diff
(99.1 %id)
R66547 placenta .d 1724 to 2038 325 to 2   fully sequenced,   324/325
(99 %)
12 diff
(96.4 %id)
AA630691   .d 1732 to 2029 325 to 28   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 298/298
(100 %)
0 diff
(100 %id)
AI758466 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1737 to 2032 297 to 1       297/297
(100 %)
1 diff
(99.7 %id)
AW518019 lymph node, lymphoma, follicular mixed small and largecell .d 1737 to 2034 299 to 2       298/299
(99 %)
0 diff
(100 %id)
AW338711 adenocarcinoma, Pancreas .d 1737 to 2029 306 to 14   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 293/293
(100 %)
0 diff
(100 %id)
AW780110 colon, moderately-differentiated adenocarcinoma .d 1737 to 2030 294 to 1       294/294
(100 %)
0 diff
(100 %id)
BE045827 follicular carcinoma, thyroid .d 1737 to 2034 298 to 1       298/298
(100 %)
0 diff
(100 %id)
FN047727 breast carcinoma .d 1738 to 1790 1 to 52       52/53
(98 %)
2 diff
(96.3 %id)
AI792252   .d 1738 to 1882 1 to 145       145/145
(100 %)
0 diff
(100 %id)
AA468708 colon .d 1750 to 2031 282 to 1       282/282
(100 %)
0 diff
(100 %id)
AA853722 Bone, Hip .d 1759 to 2034 300 to 25       276/300
(92 %)
0 diff
(100 %id)
CA444623 lung, Metastatic Chondrosarcoma .d 1765 to 2029 286 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 268/268
(100 %)
9 diff
(96.7 %id)
H61408 liver and spleen .d 1767 to 2012 247 to 1       247/253
(97 %)
2 diff
(99.3 %id)
CF123172 CNCAP(3)T-225 cell line, Prostate .d 1795 to 2029 38 to 272   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 235/272
(86 %)
6 diff
(97.8 %id)
D61754   .d 1816 to 2029 1 to 218       218/218
(100 %)
3 diff
(98.7 %id)
AA297437 gall bladder .d 1823 to 2023 200 to 1     Submitted on the opposite strand 200/211
(94 %)
1 diff
(99.6 %id)
CF891025 Human Lung Epithelial cells, lung .d 1829 to 2029 218 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 200/200
(100 %)
0 diff
(100 %id)
FN063128 breast carcinoma .d 1831 to 1962 1 to 133       133/133
(100 %)
1 diff
(99.3 %id)
AI245035 Kidney .d 1857 to 2029 173 to 1       173/173
(100 %)
0 diff
(100 %id)
FN092600 breast carcinoma .d 1891 to 2015 1 to 119       119/119
(100 %)
9 diff
(92.5 %id)
T25031   .d 1914 to 2030 119 to 3       117/119
(98 %)
0 diff
(100 %id)
D58008   .d 1941 to 2029 88 to 1   fully sequenced,   88/88
(100 %)
0 diff
(100 %id)
FN096334 breast carcinoma .d 1948 to 2028 1 to 81       81/82
(98 %)
1 diff
(98.8 %id)
AV704623 adrenal gland Gene TOB1, variant not shown         Suspected internal deletion, this clone was ignored    
AV709357 adrenal gland Gene TOB1, variant not shown         This clone was ignored    
AW389425 stomach Gene TOB1, variant not shown         This clone was ignored    
AV684141 hepatocellular carcinoma Gene TOB1, variant not shown         This clone was ignored    
AV694519 hepatocellular carcinoma Gene TOB1, variant not shown         This clone was ignored    
AV646136 corresponding non cancerous liver tissue Gene TOB1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BJ989632 hepatoblastoma Gene TOB1, variant not shown         This clone was ignored    
BG399285 Kidney Gene TOB1, variant not shown         This clone was ignored    
BG743202 skin Gene TOB1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_227712563   Gene TOB1, variant not shown       AAA This clone was ignored    
DB226373 trachea Gene TOB1, variant not shown       capped This clone was ignored    
DB349710 trachea Gene TOB1, variant not shown         This clone was ignored    
CD366922 Alveolar Macrophage, lung Gene TOB1, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI